Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Immofinanz (30/11/2021)

05.12.2021

Immofinanz: Austrian based real estate company Immofinanz delivered strong results for the first three quarters of 2021. Results of operations increased by 59.5% to Euro 180.4 min. Results from the revaluation of standing investments equalled Euro 54.0 million, compared with Euro -144.8 min in the first three quarters of 2020. Immofinanz generated net profit of Euro 295.7 mn in the first three quarters of 2021 (Q1-3 2020: Euro -98.3 mn). FFO 1, which does not include revaluation results, basically reflected the previous year at Euro 90.7 mn (Q1–3 2020: Euro 93.6 mn). This slight decline is attributable, above all, to an increase in financing costs as a result of the higher financing volume.  Dietmar Reindl, COO of Immofinanz. “Based on our very good market position, we are planning to expand the portfolio with our STOP SHOP and myhive brands from the current volume of Euro 5 bn to roughly Euro 6 bn in 2022.“ Stefan Schönauer, CFO of Immofinanz: “This growth, the further development of the portfolio and our solid financial structure represent a strong foundation for future FFO growth and our sustainable dividend policy. For the coming 2022 financial year, we expect FFO 1 before tax of more than EUR 135 million – assuming hopefully moderate COVID-19 effects – and we want to distribute roughly 70% of FFO 1 as dividends to our shareholders.“
Immofinanz: weekly performance: 4.30%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (30/11/2021)


Partners









latest 21st Austria

21st Austria weekly - Immofinanz (30/11/2021)


05.12.2021, 1479 Zeichen



Immofinanz: Austrian based real estate company Immofinanz delivered strong results for the first three quarters of 2021. Results of operations increased by 59.5% to Euro 180.4 min. Results from the revaluation of standing investments equalled Euro 54.0 million, compared with Euro -144.8 min in the first three quarters of 2020. Immofinanz generated net profit of Euro 295.7 mn in the first three quarters of 2021 (Q1-3 2020: Euro -98.3 mn). FFO 1, which does not include revaluation results, basically reflected the previous year at Euro 90.7 mn (Q1–3 2020: Euro 93.6 mn). This slight decline is attributable, above all, to an increase in financing costs as a result of the higher financing volume.  Dietmar Reindl, COO of Immofinanz. “Based on our very good market position, we are planning to expand the portfolio with our STOP SHOP and myhive brands from the current volume of Euro 5 bn to roughly Euro 6 bn in 2022.“ Stefan Schönauer, CFO of Immofinanz: “This growth, the further development of the portfolio and our solid financial structure represent a strong foundation for future FFO growth and our sustainable dividend policy. For the coming 2022 financial year, we expect FFO 1 before tax of more than EUR 135 million – assuming hopefully moderate COVID-19 effects – and we want to distribute roughly 70% of FFO 1 as dividends to our shareholders.“
Immofinanz: weekly performance: 4.30%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (30/11/2021)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Börsenradio Live-Blick, Do. 28.3.24: Heute März-Ultimo, geht sich DAX 18500 aus? Schönes bei Zalando, AT&S und Gold. Frohe Ostern!




 

Bildnachweis

Aktien auf dem Radar:Addiko Bank, Strabag, CA Immo, Flughafen Wien, Austriacard Holdings AG, Marinomed Biotech, ATX TR, S Immo, Porr, AT&S, Rosgix, RBI, Uniqa, ams-Osram, Cleen Energy, DO&CO, FACC, Lenzing, Oberbank AG Stamm, Agrana, Amag, Erste Group, EVN, Immofinanz, Österreichische Post, Polytec Group, Telekom Austria, VIG, Wienerberger, Zumtobel, Airbus Group.


Random Partner

Croma
Croma Pharma® ist ein österreichisches Familienunternehmen mit Sitz in Leobendorf. Das Unternehmen ist auf die industrielle Fertigung von Hyaluronsäure-Spritzen spezialisiert und zählt in diesem Bereich europaweit zu den führenden Experten. Das Unternehmen setzt mit eigenen Marken auf die Wachstumssparte der minimalinvasiven ästhetischen Medizin.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten